NEW YORK, Jan. 12, 2011 /PRNewswire/ — NeoStem, Inc. (NYSE
Amex:
NBS) (“NeoStem” or the “Company”), an international
biopharmaceutical company with operations in the U.S. and China,
today announced that Dr. Robin Smith, the Company’s Chairman and
CEO, will present on Wednesday, January 12, 2011 at the OneMedForum
2011 at 9:15 AM PST and at the Biotech Showcase™ 2011 at
11:00 AM PST. Both events will be held in San Francisco,
California.
The OneMedForum 2011 will be held at the Sir Francis Drake Hotel
at 450 Powell Street, San Francisco, CA and Dr. Robin Smith will
present in the Renaissance Room. The Biotech Showcase™ 2011
will be held at Parc 55 Wyndham San Francisco, CA and Dr. Robin
Smith will present in the Stockton Room.
In recapping highlights of 2010, the Company will review its
multiple accomplishments for the year. In November 2010, we
raised $19 million from two concurrent offerings. These funds will
help us to grow our revenue lines of businesses in the US and
China, including the closing of our acquisition of Progenitor Cell
Therapy LLC, and further assist in our growth. NeoStem was
also named “Best Stem Cell Company, 2010” in The New
Economy’s Biotech Awards. Additionally, The Vatican’s
Pontifical Council has undertaken to commit $1 million to joint
ventures with NeoStem and the Stem for Life Foundation, a
not-for-profit entity NeoStem participated in founding, to expand
research and raise awareness of adult stem cell therapies.We also
began generating revenues from what we believe will be just the
beginning of a pipeline of stem cell-based regenerative medicine
therapies, a key element of our growth strategy in both the United
States and China, with our collaboration with Wendeng Hospital in
China whereby patients are being offered the benefit of the latest
technology from the US in the treatment of a range of
‘/>”/>
SOURCE
